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DNA methylation is a major epigenetic mechanism
for gene silencing. Whereas methyltransferases
mediate cytosine methylation, it is less clear how
unmethylated regions in mammalian genomes are
protected from de novo methylation and whether
an active demethylating activity is involved. Here,
we show that either knockout or catalytic inactivation
of the DNA repair enzyme thymine DNA glycosylase
(TDG) leads to embryonic lethality in mice. TDG is
necessary for recruiting p300 to retinoic acid (RA)-
regulated promoters, protection of CpG islands
from hypermethylation, and active demethylation of
tissue-specific developmentally and hormonally re-
gulated promoters and enhancers. TDG interacts
with the deaminase AID and the damage response
protein GADD45a. These findings highlight a dual
role for TDG in promoting proper epigenetic states
during development and suggest a two-step mecha-
nism for DNA demethylation in mammals, whereby
5-methylcytosine and 5-hydroxymethylcytosine are
first deaminated by AID to thymine and 5-hydroxy-
methyluracil, respectively, followed by TDG-medi-
ated thymine and 5-hydroxymethyluracil excision
repair.INTRODUCTION
Cytosine methylation—the formation of 5-methylcytosine (5mC)
at CpG sites—is an important epigenetic modification used by
mammals to mediate transcriptional regulation, including tran-
scriptional repression, X chromosome inactivation, imprinting,
and suppression of parasitic sequences (Bird, 1992; Kass
et al., 1997; Siegfried and Cedar, 1997). The establishment and
maintenance of the correct DNA methylation patterns at CpG
sites is essential in mammals during development, gametogen-
esis, and differentiation of somatic tissues. Indeed, alterations
in DNA methylation patterns, with the associated chromatin
changes, have profound consequences, as demonstrated by
embryonic lethality in the absence of DNA methylation (Li
et al., 1992; Okano et al., 1999), developmental defects and
accelerated aging in cloned mammals (Rideout et al., 2001),
and characteristic epigenetic changes in cancer, such as global
genome hypomethylation and tumor suppressor gene hyperme-
thylation (Feinberg and Tycko, 2004; Jones and Laird, 1999).
Whereas DNAmethylation is mediated by de novo DNAmeth-
yltransferases (DNMT3a and DNMT3b) that act on unmethylated
DNA and maintenance DNA methyltransferases (DNMT1) that
act on newly replicated, transiently hemimethylated DNA, the
demethylating activities or processes that remove methylation
marks in mammals are largely unknown. Indeed, it has been
controversial as to whether demethylation is an active process
in mammals (Ooi and Bestor, 2008) and which mechanisms
are involved (Wu and Zhang, 2010).Cell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc. 67
Demethylation can occur passively due to replication in the
absence of remethylation, with consequent dilution of this modi-
fication. However, there is evidence supporting the occurrence
of active demethylation in mammals, including demethylation
of the paternal genome shortly after fertilization (Mayer et al.,
2000; Oswald et al., 2000), demethylation to erase and reset
imprinting in primordial germ cells (Reik et al., 2001; Surani
et al., 2007), and demethylation during somatic differentiation
of the developing embryo to establish tissue-specific gene
expression patterns (Kress et al., 2006; Niehrs, 2009) and during
gene activation in adult kidney (Kim et al., 2009) and brain (Ma
et al., 2009). In addition, it is generally thought that active tran-
scription contributes to the maintenance of the unmethylated
state of promoter-associated CpG-rich sequences known as
CpG islands, but the molecular details of protection from hyper-
methylation and the potential involvement of an active demethy-
lation process are unknown (Illingworth and Bird, 2009).
Accumulating evidence in nonmammalian model organisms
points to the involvement of DNA repairmechanisms in active de-
methylation (Gehring et al., 2009; Niehrs, 2009). In Arabidopsis,
the base excision repair (BER) proteins Demeter andROS1 affect
demethylation by directly removing 5mC through their glycosy-
lase activities (Gehring et al., 2006; Morales-Ruiz et al., 2006).
In Xenopus, demethylation has been reported to be initiated by
the genome stability protein Gadd45a (growth arrest and DNA
damage-inducible protein 45 a) in a process dependent on the
nucleotide excision repair protein XPG (Barreto et al., 2007);
however, the role of mammalian GADD45 in demethylation (Bar-
reto et al., 2007; Schmitz et al., 2009) has been challenged (Jin
et al., 2008). In zebrafish embryos, rapid demethylation of exog-
enous and genomicDNAoccurs in two coupled steps: enzymatic
5mC deamination to thymine by activation-induced deaminase
(AID) or apolipoprotein B RNA-editing catalytic component 2b
and 2a (Apobec2b, 2a), followed by removal of the mismatched
thymine by the zebrafish thymine glycosylase MBD4, with
Gadd45 promoting the reaction (Rai et al., 2008). Recently, 5-hy-
droxymethylcytosine (5hmC), an oxidative product of 5mC
generated by the Tet hydroxylases (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009), has been proposed as a demethyla-
tion intermediate (Globisch et al., 2010; Wu and Zhang, 2010).
During gene activation in the adult mouse brain, demethylation
by TET1-mediated hydroxylation of 5meC to 5hmC was pro-
moted by AID/Apobec deaminases in a process that generates
5-hydroxymethyluracil (5hmU) and ultimately requires BER,
although the specific glycosylases involved were not identified
(Guo et al., 2011).
Numerous in vitro studies have documented a potential role of
the BER enzyme TDG (thymine DNA glycosylase) in transcrip-
tional regulation and demethylation. Indeed, TDG interacts with
several transcription factors, including retinoic acid receptor
(RAR), retinoid X receptor (RXR) (Um et al., 1998), estrogen
receptor a (ERa) (Chen et al., 2003), thyroid transcription factor
1 (TTF1) (Missero et al., 2001), and histone acetyl-transferases
p300 and CBP (Tini et al., 2002). It has been proposed that
TDGmaybe responsible for demethylation either throughadirect
5mC glycosylase activity (Zhu et al., 2000) or indirectly by acting
onG:Tmismatches originated by a controlled deaminase activity
of DNMT3a and DNMT3b (Me´tivier et al., 2008). Very recently,68 Cell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc.TDGwas shown to be involved in maintaining active and bivalent
chromatin marks in mouse embryo fibroblasts and ES cells
undergoing neuronal differentiation, respectively, but the mech-
anism for such epigenetic effects and the requirement of its
catalytic activity were not clarified (Corta´zar et al., 2011). To
investigate the functional role of TDG in epigenetic regulation,
DNA demethylation, and mammalian development, we gener-
ated mice with targeted inactivation of the Tdg gene. Tdg null
embryos die in midgestation and exhibit a complex develop-
mental phenotype that appears to derive from the failure to
establish and maintain proper DNA methylation patterns at
promoters and enhancers. A knockin mutation that inactivates
the glycosylase function of TDG is also embryonically lethal,
and TDG is found in a complex with AID and GADD45a. These
findings suggest a two-step catalytic mechanism for DNA deme-
thylation that is essential for mammalian development.
RESULTS
Generation of Tdg Null Mice
The Tdg gene was deleted in mice by homologous recombina-
tion, using a targeting construct that removed exons 3–7, corre-
sponding to most of the catalytic domain (Figure S1 available
online). The resulting Tdg allele does not produce detectable
protein by western blotting (Figure 1A), suggesting that it is
null. TDG is dispensable for efficient uracil removal from G:U
mismatches (Figure S2). However, removal of the mispaired
thymine from G:T mismatch-containing oligonucleotides is virtu-
ally abrogated in Tdg/ homozygous mouse embryo fibroblast
(MEF, vide infra) nuclear extracts (Figure 1B), thus confirming
that Tdg is a null allele and suggesting that TDG is the predom-
inant G:T mismatch repair activity in MEFs.
Lethality and Complex Developmental Phenotype
of Tdg Null Embryos
Whereas heterozygous Tdg+/ mice are viable and fertile and
show no obvious phenotype, homozygosity for the null Tdg allele
leads to embryonic lethality. In fact, when heterozygous Tdg+/
mice were interbred, no live birth Tdg/ homozygotes were
derived. Specifically, the numbers of wild-type, heterozygous,
and homozygous mutant pups obtained were 11, 29, and 0,
respectively, which is significantly different from the expected
Mendelian ratios (p < 0.0008 by c2). To examine in detail the
embryonic lethality, timed matings were set up between
Tdg+/ heterozygotes, and pregnant mice were sacrificed at
different gestation times, ranging from embryonic day (E) 10.5
to E14.5. This analysis revealed an arrest of development
associated with Tdg nullizygosity at E11.5; at later gestation
times, homozygous mutant embryos are beginning to be re-
sorbed (E12.5–13.5) or are completely resorbed and never de-
tected (E14.5) (Table S1). At E11.5, developmentally arrested
Tdg null embryos manifest a complex phenotype characterized
macroscopically by abdominal (liver) hemorrhage, pericardial
edema/hemorrhage, hypoplastic branchial arches, delayed
limb development, prominent telencephalic vesicles, and diffuse
hemorrhagic lesions (Figures 1C, 1D, 1G, and 1H).
Microscopically, Tdg null embryos exhibit specific patterning
defects of the developing heart, with the most significant
Figure 1. Developmental Defects in Tdg Null Embryos
(A) The expression of TDG was monitored by western blot. No expression was detected in MEFs homozygous for the Tdg allele, whereas heterozygous MEFs
showed reduced expression compared to wild-type cells.
(B) TDG is the foremost G:T mismatch repair activity at CpG dinucleotides in MEFs. Repair of a double-stranded oligonucleotide containing a G:T mismatch
by nuclear extracts of MEFs with different genotypes, in comparison to a substrate neither exposed to lysate nor enzyme (O). Reaction with recombinant
MBD4/MED1 (rM) was used as a size marker for cleavage at the mismatched thymine.
(C and D) Gross phenotype of wild-type and Tdg/ littermate embryos at embryonic day E11.5. Double arrows show constriction in the cervical region of Tdg null
embryos (D) compared to wild-type embryos (C); white asterisks mark the carotid artery that is stenotic in Tdg null embryos; the enlarged heart with pericardial
effusion (h) and hemorrhagic liver (l) are apparent; arrowheads point to hemorrhagic lesions in the cranium and enlarged and irregular segmental arteries.
(E and F) Cardiac perfusionwith India ink inwild-type and Tdgmutant embryos at E11. In Tdg null embryo (F), circulatory insufficiency is demonstrated by reduced
perfusion of the dorsal aorta (da) and carotid artery (ca), whereas the third (a3) and fourth (a4) branchial arch arteries are enlarged in comparison to wild-type
embryos (E). The first (b1) and second (b2) branchial arches, as well as the otic vesicle (ov), are indicated.
(G and H) Transverse sections of the liver at E11. Compared to wild-type (G), the mutant liver has enlarged hepatic sinusoids, the likely proximal causes of
abdominal hemorrhage.
(I and J) Transverse sections of the heart at E11.5 show patterning defects in mutant embryos. The conal part of the OFT is severely hyperplastic in mutant
embryos (twin arrows in J) when compared to the heterozygous specimen (I), generating an atypical indentation between the right ventricle (RV) and OFT (arrow
head in J); the characteristic ‘‘dog leg bend’’ of the OFT, which is responsible for correctly positioning the OFT over the midline of left ventricle (LV) and RV, is not
observed in mutant hearts. Instead, the OFT is situated right above the RV. As a result, the left part of the body wall is pushed out by the LV (asterisks).
(K and L) Immunostaining of the vascular labyrinth with a PECAM/CD31 antibody in wild-type (K) and Tdg null (L) embryos at E11 reveal a generalized disor-
ganization of the vascular network in the latter. Arrowheads point to irregular branches of the internal carotid with varicosities, bulges, and ectasias.
See also Figure S1, Figure S2, and Figure S3.abnormalities seen in the outflow tract (OFT) (Figure 1I and 1J
and Figures S3A–S3D); vasculogenesis defects of dorsal aortae,
carotid arteries, and branchial arteries (Figures 1E and 1F); and
generalized defect of angiogenesis, particularly evident as
altered branching of the internal carotid (Figure 1F) and the coro-
naries (Figures S3E and S3F).
TDG has two proposed roles in mutational avoidance (DNA
repair) and transcriptional regulation (Corta´zar et al., 2007). The
embryo phenotype was fully penetrant and reproducible, which
is inconsistent with an antimutagenic DNA repair defect that
would be expected to yield a variable, heterogeneous phenotype
caused by stochastic secondary mutations at different target
genes. We therefore focused on the role of TDG in transcription
as a possible mechanistic explanation of the phenotype.
Remarkably, many features of the phenotype of Tdg null
embryos (altered vasculogenesis and angiogenesis, hemor-
rhagic lesions, heart abnormalities with thinning of the myocar-
dium, and pericardial effusion) have been previously describedfor either Cbp/ or p300/ embryos (Tanaka et al., 2000; Yao
et al., 1998). Similarly, some other specific phenotypic features
in Tdg null embryos (OFT septation defects, hypoplasticmyocar-
dium, abnormal great arteries derived from branchial arches,
delayed limbs) resemble those of embryos deficient in various
Rar and Rxr genes (Mark et al., 2006) or hypomorphic for retinal-
dehyde dehydrogenase, the enzyme involved in RA biosynthesis
(Vermot et al., 2003). We infer that the lethality phenotype is
likely related to the inactivation of a developmentally relevant,
transcription-related function of TDG. In order to investigate
this issue directly, we established MEF lines from Tdg null
embryos.
Attenuated RA-Dependent Transcription
and Altered p300 Recruitment in Tdg Null MEFs
We hypothesized that, given the phenotypic features described
above, it is possible that RAR/RXR and p300 activity might be
reduced in the absence of TDG. Indeed, assay of p300 activityCell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc. 69
Figure 2. Involvement of TDG in Tran-
scription and Composition of RAR-p300
Complexes
(A) Reduced p300-induced transcriptional activa-
tion in Tdg/ MEFs. Luciferase activity of a Gal4
operator luciferase reporter cotransfected with a
Gal4 DNA-binding domain-p300 fusion construct
and normalized to transfection efficiency using
b-galactosidase expression. Because the trans-
fected plasmids are unmethylated, this assay
reflects only the coactivator role of TDG.
(B) Reduced retinoic-dependent RAR/RXR tran-
scriptional activity in Tdg/MEFs. CAT activity of
a RARE-containing reporter was normalized to
transfection efficiency using b-galactosidase
expression.
(C) Co-IP with an antibody capable of recognizing
all of the RARs shows lack of association between
RAR and p300 in Tdg/ MEFs. Wild-type and
mutant MEFswere stimulated with 1 mMRA for the
indicated time. Approximately equal levels of p300
and RAR are present in wild-type andmutant cells.
Detection of b-actin is shown as a loading control.
(D and E) Chromatin immunoprecipitation shows
that TDG binds directly to the promoter of two
differentially expressed RAR-RXR target genes,
Crabp2 (D) and Rbp1 (E), and is required for p300
recruitment and histone H3 acetylation. Approxi-
mately equal amounts of input chromatin were
used for immunoprecipitation. As negative control,
immunoprecipitation with nonspecific immuno-
globulins was performed.
Data are presented as mean ± standard error of
the mean (SEM). See also Figure S4.with reporter constructs indicated that transcriptional coactiva-
tion by this acetyltransferase is significantly reduced in two inde-
pendent Tdg/MEF lines in comparison to wild-type MEF lines
(Figure 2A). RA-dependent RAR/RXR transcriptional activity is
also attenuated in Tdg null MEFs (Figure 2B).
To clarify the role of TDG in transcription, we compared the
transcriptome of wild-type and Tdg null MEFs. In keeping with
a role of TDG in transcriptional activation, of the 108 differentially
expressed genes from 120 probe sets, approximately three-
fourths of the genes were downregulated in its absence (Table
S2). The differentially expressed genes were analyzed with
gene ontology and pathway analysis applications. Remarkably,
the pathway/network with the highest score was centered
around RA (Figure S4) and comprised retinol biosynthesis and
RA-dependent target genes downregulated in Tdg null MEFs,
including those encoding cellular retinoic acid-binding protein
2 (Crabp2, 15.3-fold), retinol-binding protein 1 (Rbp1, 9.3-fold),
Igfbp6 (16.3-fold), embryonal fyn-associated substrate (Efs, 6-
fold), and Rai14 (1.9-fold). These observations indicate that
TDG is a positive regulator of transcription, particularly p300-
and RAR/RXR-dependent transcription.
To define the role of TDG in RA-dependent transcription, we
examined the composition of RAR-containing complexes by
coimmunoprecipitation (co-IP) and found that p300 is in a
complex with RAR/RXR in wild-type MEFs, but not in Tdg null
MEFs, despite the presence of approximately equal levels of
p300 and RAR in total lysates (Figure 2C). In addition, RARs70 Cell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc.occupy retinoic acid response elements (RARE) on the Crabp2
and Rbp1 promoters in both wild-type and Tdg null cells, but in
theabsenceofTDG, there is little recruitmentofp300anda reduc-
tion in the presence of its product, acetylated histone H3 (Figures
2D and 2E). These findings are consistent with the differential
expression of Crabp2 and Rbp1 and indicate that TDG has an
obligatory direct role in their proper transcriptional regulation.
Altered DNA Methylation Patterns in Tdg Null Cells
and Tissues
Given the possible role of TDG in demethylation (Me´tivier et al.,
2008; Zhu et al., 2000), we examined the DNA methylation
patterns of promoters of select genes that were differentially ex-
pressed between wild-type and Tdg null MEFs using sodium
bisulfite/DNA sequencing. In Tdg null MEFs, the downregulated
genes contain a CpG island within 2 kb of sequence upstream
of the transcriptional start site and are hypermethylated,
including Efs, Crabp2, Hoxa5, and H19 (Figures 3A–3D).
Because these CpG islands and the maternal allele of the im-
printed H19 gene are unmethylated in zygotes, ES cells, and
the soma (Mohn et al., 2008; Reese and Bartolomei, 2006;
data not shown), this observation suggests that, in the absence
of TDG, sequences that are normally kept unmethylated suc-
cumb to hypermethylation, likely as a consequence of unsched-
uled de novo methylation.
To rule out the possibility that hypermethylation was caused
by the in vitro culture stress of MEFs (Pantoja et al., 2005), we
Figure 3. Hypermethylation of CpG Islands
in the Absence of TDG
(A–D) DNA methylation analysis by sodium bisul-
fite modification and sequencing of cloned PCR
products in wild-type and Tdg null cells. Open and
closed circles represent unmethylated and meth-
ylated CpGs, respectively.Crabp2 (A), Efs (C), and
Hoxa5 (D) promoters are unmethylated at various
degrees in wild-type cells, whereas their CpG
islands are hypermethylated in Tdg null MEFs. For
the H19 promoter (B), the first three clones in
wild-type MEFs are likely derivatives of the inac-
tive paternal allele, and the remaining ones are
probably of maternal origin (H19 is maternally ex-
pressed), whereas in Tdg null MEFs, both alleles
are hypermethylated.
(E) Analysis of the 30 half of the Igf2DMR2. The first
five clones in wild-type PGCs are likely derived
from the paternal (methylated) allele, and the re-
maining ones are probably of maternal origin,
whereas in Tdg null PGCs, all of the alleles are
hypermethylated.
See also Figure S4.analyzed the methylation pattern of the imprinted gene Igf2 in
wild-type and Tdg mutant primordial germ cells (PGCs) isolated
from E11 embryos (prior to the onset of lethality). Whereas wild-
type E11 PGCs show the typical methylation profile of maternal
unmethylated and paternal methylated alleles at the Igf2 differ-
entially methylated region 2 (DMR2), all of the alleles sequenced
in Tdg mutant PGCs, presumably including those of maternal
origin, are methylated (Figure 3E). Although it is currently unclear
whether TDG has any specific role in the establishment or main-
tenance of imprinting, these data confirm a TDG-dependent
protection from hypermethylation in early development.
The observed protective function begs the question of
whether TDG might also have a role in DNA demethylation.
During development, highly conserved noncoding elements
and enhancers undergo demethylation in a process linked to
tissue-specific gene expression and differentiation (Kress
et al., 2006; Niehrs, 2009). One such example is the albumin
gene (Alb1) enhancer, whose five CpG dinucleotides are
progressively demethylated during liver development and are
associated with Alb1 mRNA transcription (Xu et al., 2007). Anal-
ysis of these sites revealed that they remain methylated in Tdg
null liver at midgestation, in a configuration similar to that of a
nonalbumin-producing organ, e.g., brain (Figures 4A and 4B).Cell 146,This correlated with inefficient Alb1
mRNA transcription in the Tdg null liver
(Figure 4C).
The glucocorticoid-responsive unit
(GRU) of the tyrosine aminotransferase
(Tat) gene enhancer undergoes demethy-
lation at midgestation in the developing
rat liver in a process stimulated by the
prenatal peak of glucocorticoids (Tho-
massin et al., 2001). Demethylation of
this enhancer is associated with single-
strand nicks 30 to the 5mC, leading to
the suggestion that a demethylating activity initiates base or
nucleotide excision repair at these sites (Kress et al., 2006).
We found that demethylation of five CpG sites at the GRU of
the murine Tat enhancer begins at midgestation and is depen-
dent on TDG (Figures 4D and 4E).
Taken together, these observations indicate that TDG is
required for the establishment of proper DNA methylation
patterns that are conducive to transcription of developmentally
and hormonally regulated genes and of tissue-specific genes,
both by guarding from CpG island hypermethylation and pro-
moting selective demethylation events.
Involvement of TDG in Active DNA Demethylation
Whereas protection against CpG island hypermethylation might
be, in principle, a reflection of the coactivator function of TDG,
the involvement of this enzyme in DNA demethylation suggests
an active catalytic role. In order to determine directly whether
TDG is involved in active DNA demethylation, we studied the
transcriptional reactivation of a heterologous in vitro-methylated
Oct4 pluripotency gene in embryonic carcinoma P19 cells or in
the same cells expressing either an shRNA (C8) targeting TDG
or a control shRNA (C7) (Figure 4F). We used anOct4 promoter::
EGFP reporter assay in which reactivation of EGFP expression is67–79, July 8, 2011 ª2011 Elsevier Inc. 71
Figure 4. TDG Is Involved in DNA Demethylation
(A) DNAmethylation analysis of five CpG dinucleotides of the Alb1 enhancer in liver and brain of wild-type and Tdg null embryos at E11. The numbers refer to the
position of CpGs relative to the transcription start site (TSS).
(B) Corresponding quantification and color-coded display of percent of DNA methylation at each CpG dinucleotide of the Alb1 enhancer.
(C) Real-time RT-PCR quantification of Alb1 mRNA expression, normalized to Hprt mRNA expression, in wild-type and Tdg null livers at E11.
(D) Methylated DNA immunoprecipitation quantitative PCR (MeDIP-qPCR) analysis of methylation levels at the Tat gene GRU, expressed as percent of
immunoprecipitated DNA relative to input DNA, in ES cells, wild-type, and Tdg null embryos at E10.5 (headless embryo body dissected to enrich for liver).
(E) Methylation analysis by sodium bisulfite modification and sequencing of five CpG dinucleotides of the Tat gene GRU (at 2520, 2485, 2473, 2390,
and 2386 bp relative to TSS) in ES cells, wild-type, and Tdg null embryos at E10.5 (dissected to enrich for liver). Two-sided Fisher’s exact test at the 5%
significance level.
(F) Western blot analysis showing effective downregulation of TDG in P19 C8 cells expressing a short hairpin RNA (shRNA) directed against murine TdgmRNA in
comparison to parental P19 cells and control shRNA P19 C7 cells.
(G) Detection by fluorescence of GFP+ cells (top) in cultures of parental P19, TDG-shRNA-containing P19 C8 cells and control shRNA C7 cells, transfected with
unmethylated and SssI-methylated human Oct4::EGFP reporter. Cells were plated at approximately equal density, as evidenced by phase contrast microscopy
(bottom).
(H) Quantitation of expression of unmethylated and SssI-methylated human Oct4::EGFP reporter in P19, TDG-shRNA C8, and control shRNA C7 cells.
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due to demethylation of the heterologous Oct4 promoter (Bar-
reto et al., 2007). We found that the unmethylated Oct4::EGFP
reporter was expressed within 12 hr of transfection in both
parental P19 cells and its derivative line C8 bearing the TDG
knockdown (the 2.3-fold expression differential between P19
and C8 likely reflects the coactivator function of TDG). In
contrast, the methylated reporter is efficiently expressed only
in parental P19 cells but not C8 cells (6-fold expression differen-
tial). The C7 cells expressing a control shRNA and P19 cells in-
fected with a scrambled shRNA behaved similarly to the parental
P19 line (Figures 4G and 4H and data not shown). A bisulfite
sequencing analysis of the transgene recovered after 12 hr
from transfected cell lines revealed that demethylation of the
proximal region of the Oct4 promoter is compromised in the
Tdg knockdown cells, thus establishing a direct effect of TDG
on demethylation (Figure 4I). The short time frame of the deme-
thylation and the fact that the reporter plasmid used lacks an
origin of replication rule out any potential effect of passive deme-
thylation and confirm that TDG is involved in an active demethy-
lation process.
The DNA Glycosylase Activity of TDG Is Required
for Development and DNA Demethylation
If TDG has a catalytic role in DNAdemethylation, the prediction is
that an inactivating point mutation at the glycosylase active site
would reproduce the embryonic lethality. On the other hand, lack
of lethality of such mutation would suggest that TDG affects
methylation patterns and development as a reflection of its coac-
tivator function. We tested these two possibilities by generating
a knockin mouse strain (Figure S1) expressing a point mutation
(N151A) in the TDG glycosylase domain (Figures 5A and 5B)
that eliminates the obligatory asparagine residue at the TDG
active site (Hardeland et al., 2000) and abrogates glycosylase
activity (Figure 5C). Live birth TdgN151A/N151A homozygotes
were never derived from the breeding of heterozygotes, indi-
cating that, indeed, TDG glycosylase activity is required for
embryonic development. Remarkably, analysis of timed matings
revealed that lethality occurs even earlier than in knockout
embryos, i.e., at E10.5. TdgN151A/N151A embryos are much
smaller than wild-type littermates and show general develop-
mental delay, turning defect, and pericardial effusion (Figure 5D).
Importantly, DNA demethylation of the Tat enhancer was abro-
gated in TdgN151A/N151A embryos (Figure 5E). We conclude that
the catalytic activity of TDG is essential for development and
DNA demethylation.
TDG Is in a Complex with AID and GADD45a
A direct 5mC glycosylase activity of TDG has been reported (Zhu
et al., 2000), but we were unable to detect such activity using
a preparation of recombinant TDG that was extremely active
on its cognate G:T mismatched substrates (Figure S5A). In ze-
brafish embryos, demethylation is initiated by enzymatic deam-
ination of 5mC to T by AID, Apobec2a, or Apobec2b, followed by(I) DNA methylation analysis by sodium bisulfite modification and sequencing o
promoter from the untransfected methylated Oct4::EGFP reporter and the same
exact test at the 5% significance level.
Data are presented as mean ± SEM.MBD4 glycosylase removal of the mismatched T in a reaction
promoted by GADD45 (Rai et al., 2008). We therefore set out
to determine whether TDG may mediate DNA demethylation
in a similar two-step mechanism by interacting with AID/Apobec
members and GADD45a in mammalian cells.
Co-IP experiments conducted in HEK293 cells transfected
with cDNAs encoding tagged versions of TDG, AID, Apobec1,
and GADD45a revealed that TDG forms a complex with AID
(Figures 6A and 6B, lane 6) and GADD45a (Figures 6A and 6B,
lane 8). In addition, transfected AID and GADD45a co-IP with
endogenous TDG (Figure 6B, lanes 3 and 5). The interaction of
TDG with AID is specific, as TDG does not co-IP with the AID-
related family member Apobec1 (Figures 6A and 6B, lane 7).
Furthermore, AID interacts with GADD45a (Figure 6C, lane 4) in
a TDG-independent manner, as shown by co-IP in two cell lines
having undetectable levels of TDG (Figures 6D and 6E).
We further tested whether these interactions are taking place
at endogenous levels of expression in the developmentally
relevant context of embryonic carcinoma P19 cells and terato-
carcinoma F9 cells exhibiting high and low levels, respectively,
of TDG and AID. Co-IP experiments conducted on endogenous
lysates demonstrated that, in P19 cells, TDG interacts with AID
(Figure 6F, top, lane 2) and that AID and GADD45a also interact
(Figure 6F, second panel, lane 2). These interactions were not
detected in F9 cells, likely due to the very low levels of TDG
and AID expression. Interestingly, shRNA-mediated downregu-
lation of TDG in the P19-derived C8 cells leads to reduction of
AID expression (Figure 6G), suggesting that TDG may regulate
the levels and/or the stability of AID. Recombinant AID and
recombinant GADD45a-purified proteins directly interact, as
do recombinant AID and recombinant TDG, albeit with lower
affinity (Figure 6H). One possible difference to explain the
stronger interaction detected in cells is that the latter may be
mediated by posttranslational modifications not present in the
recombinant proteins.We conclude that the TDG-AID-GADD45a
interaction occurs in vivo and has functional consequences for
AID levels.
Interestingly, the TDG N151A protein retains interaction with
AID and GADD45a (Figure S6), suggesting that the more severe
phenotype of the TdgN151A/N151A compared to the Tdg knockout
embryosmight be due to a dominant-negative action of the cata-
lytically deadmutant protein in sequestering AID andGADD45 or
other interactors in nonfunctional, nonproductive complexes.
TDG Has Glycosylase Activity on 5hmU
Because 5hmC, the hydroxylation product of 5mC, has been
proposed as an intermediate in demethylation, we assayed but
failed to detect 5hmC glycosylase activity for TDG or any other
related glycosylases (Figure S5B). However, during active DNA
demethylation in mammalian cells, AID/Apobec deaminases
convert 5hmC to 5hmU for subsequent processing by BER
(Guo et al., 2011). We therefore assayed the 5hmU glycosylase
activity of TDGand related glycosylases. As previously describedf the proximal region (region 8) (Deb-Rinker et al., 2005) of the human Oct4
reporter transfected and recovered from P19 and C8 cells. Two-sided Fisher’s
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Figure 5. The DNA Glycosylase Activity of TDG Is Required for Development and DNA Demethylation
(A) Sequence analysis of a cDNA fragment encompassing the relevant Tdg exon 4 region from wild-type and TdgN151A/N151A E10.5 embryo total RNA confirms
expression of the knockin allele.
(B) Western blot analysis with an anti-TDG antibody reveals expression of the wild-type and TDGN151A protein in E10.5 embryo lysates of corresponding
genotypes.
(C) Repair of a double-stranded oligonucleotide containing a G:T mismatch by nuclear extracts of whole E10.5 embryo extracts of the indicated genotypes.
(D) Gross phenotype of wild-type (left) and TdgN151A/N151A (right) littermate embryos at embryonic day E10.5. Scale bar, 750 mm.
(E) Methylation analysis by sodium bisulfite modification and sequencing of five CpG dinucleotides of the Tat gene GRU in a TdgN151A/N151A E10.5 embryo
(headless embryo body preparations dissected to enrich for liver). Comparison of methylation levels with the wild-type embryo in Figure 4E was made using the
two-sided Fisher’s exact test at the 5% significance level and revealed a p value equal to 0.0004.
See also Figure S1.(Haushalter et al., 1999), SMUG1 has activity on 5hmU in single-
strandDNA orwhen pairedwith adenine in double-strandDNA to
resemble an expected product of thymine oxidation (Figure 7A).
Remarkably, similar to a sequence-unrelated thermophilic Tdg
(Baker et al., 2002), mammalian TDG exhibits robust activity,
comparable to SMUG1, on a 5hmU:Gmismatch in double-strand
DNA, the expected product of deamination following hydroxyl-
ation of 5mC (Figure 7A). This result expands the suggested
role of TDG downstream of deamination to include initiation of
BER following hydroxylation of 5mC (Figure 7B).
Lack of Promoter Mutations in TdgMutant Cells
Deamination of 5mC or 5hmC in the absence of TDG-mediated
repair of the resulting G:T or G:5hmU mismatch is expected to
increase G:C-to-A:T transition mutations. For this reason, we
conducted a sequence analysis of nonbisulfite-modified DNA74 Cell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc.of promoters undergoing TDG-dependent protection from
hypermethylation or DNA demethylation. Nomutation was found
in H19, Efs, HoxA5, and Crabp2 promoters in Tdg mutant MEFs
or at the Oct4 promoter of the Oct4::EGFP transgene recovered
from the C8 Tdg knockdown cells (data not shown). Although a
possible compensation by MBD4, SMUG1, or mismatch repair
cannot be ruled out, this result suggests the possibility that the
deamination and glycosylase steps are coordinated, such that
deamination does not occur in the absence of TDG.
DISCUSSION
Our results demonstrate that TDG is required for normal mam-
malian development and the establishment of proper pro-
moter/enhancer DNA methylation patterns that are conducive
to transcription during embryogenesis. Failure to establish and
Figure 6. TDG Is in a Complex with AID and GADD45a
(A–D) Immunoprecipitates of lysates of HEK293 (A–C) or A549 and U251 (D) cells transfected with hemagglutinin (HA)-, FLAG-, or MYC-tagged expression
constructs were resolved by PAGE and detected by western blotting with the indicated antibodies. Western blotting of lysates shows that identical tagged
constructs were expressed at approximately equal levels. In these and other western blots, the presence of additional TDG bands is the result of SUMOylation or
other posttranslational modifications (Corta´zar et al., 2007). Note that, in (B), FLAG-tagged AID and FLAG-tagged GADD45a immunoprecipitate not only with
exogenous HA-tagged TDG (lanes 6 and 8), but also with endogenous TDG (lanes 3 and 5).
(E) Western blotting with an anti-TDG antibody reveals TDG expression in HEK293 cells, but not in A549 or U251 cells.
(F) Coimmunoprecipitation experiments with the indicated antibodies show that AID forms a complex with TDG and GADD45a at endogenous levels of
expression in P19 embryonic carcinoma cells. Western blotting with anti-AID antibody confirms that AID was actually immunoprecipitated.
(G) AID levels are reduced by shRNA in the P19 derivative, TDG knockdown cell line C8, as evidenced by western blotting of lysates with the indicated anti-TDG
and anti-AID antibodies. Western blotting with an anti-b-actin antibody acts as a loading control.
(H) The indicated recombinant proteins were premixed, and themixtures were immunoprecipitated with an anti-AID antibody. Immunoprecipitates along with the
input recombinant TDG or GADD45a were detected by western blotting with an anti-TDG or anti-GADD45a antibody, as indicated. GADD45a is readily detected,
whereas only a small amount of TDG (visible in the longer exposure, bottom-left) precipitates with AID, suggesting a low-affinity interaction.
See also Figure S5 and Figure S6.maintain correct DNA methylation patterns is likely the cause of
lethality and the observed complex developmental phenotype,
as it is known that even small changes in DNAmethylation cause
abnormalities or lethality (Gaudet et al., 2003).
In maintaining the proper epigenetic states, TDG apparently
has a dual role: protection from aberrant hypermethylation
(examples include the CpG islands of Efs, HoxA5, and Crabp2
in MEFs and the maternal alleles of H19 and Igf2 DMR2 in
MEFs and PGCs) and promotion of demethylation (exemplified
by the Alb1 and Tat enhancers in hepatoblasts and the
Oct4::EGFP reporter in P19 cells).
Our combined biochemical and developmental data suggest
that demethylation is an active process requiring TDG catalytic
activity immediately downstream of the deaminase-catalyzed
conversion of 5mC into thymine and/or of 5hmC into 5hmU.
Thus, both the 5mCdeamination and hydroxylation-deaminationpathways may converge on TDG (Figure 7B), and perhaps
this convergence may explain the absolute requirement of
TDG during embryogenesis, although the relative prevalence of
each pathway in different developmental contexts is currently
unknown. The extent of possible partial compensation by
activities of MBD4 and SMUG1 is also unknown, although the
observed lethality of the Tdg knockout suggests that it is not
sufficient to maintain embryogenesis.
Similarity of the lethal phenotype of the Tdg knockin and
knockout embryos and, in turn, their resemblance to the p300/
Cbp and Rar/Rxr mutant embryos strongly suggest the possi-
bility that protection from aberrant de novo methylation may
also involve an active process, requiring TDG glycosylase
activity to constantly antagonizemethylation. However, a nonca-
talytic role of TDG cannot be ruled out completely, and it is
possible that protection from hypermethylation may occur atCell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc. 75
Figure 7. TDG Glycosylase Activity on 5hmU and Model of the Role of TDG in DNA Demethylation Pathways
(A) Recombinant TDG and related glycosylases were incubated with 5hmU-containing single-strand oligonucleotide or double-strand oligonucleotides bearing
5hmU:A pairing or 5hmU:G mismatch, all 32P labeled on the 5hmU strand. The resulting AP site was cleaved with alkali at high temperature.
(B) Schematic of the involvement of TDG in both the deamination and hydroxylation-deamination pathways of DNA demethylation. Lethality/viability of the
glycosylase knockout mice is indicated.
See also Figure S5 and Figure S7.least in part via TDG inhibition of de novo DNA methyltrans-
ferases (Li et al., 2007).
Our observation that TDG is required for the interaction of
RAR/RXR with p300 both on and off the DNA suggests a model
in which transcription factor binding (which is TDG independent;
Figures 2D and 2E) may be responsible for tethering TDG to
the promoter/enhancer (Figure S7). Thus, it is possible that the
TDG-provoked demethylation of differentiation-associated
promoters/enhancers depends on TDG tethering by tissue-
specific transcription factors. Of note, GADD45 is known to
bind to nuclear hormone receptors (Yi et al., 2000) and preferen-
tially to hyperacetylated nucleosomes (Carrier et al., 1999), sug-
gesting that GADD45 may also be involved in targeting
promoters for demethylation. In this model, proper targeting of
AID may, in turn, depend on its interaction with GADD45 and
TDG. Future binding studies conducted on a genomic scale in
different tissues and at various developmental stages will further
define the promoters/enhancers that are direct targets of the
TDG-AID-GADD45a complex.
The identification of a ternary complex containing TDG, AID,
and GADD45a is consistent with the recent recognition of AID
as a factor required for DNA demethylation during reprogram-
ming of somatic cells (Bhutani et al., 2010) and erasure of DNA
methylation at imprinted and other loci in PGCs (Popp et al.,
2010), as well as with the role of GADD45a (Barreto et al.,
2007; Schmitz et al., 2009) and the related GADD45b (Ma
et al., 2009) in demethylation of specific promoters. It is also
consistent with the role of BER in genome-wide active DNA
demethylation in PGCs (Hajkova et al., 2010). However, Aid-defi-
cient mice are viable and fertile (Muramatsu et al., 2000; Revy
et al., 2000), which suggests that TDG may also function down-
stream of Apobec deaminases and possibly engage different76 Cell 146, 67–79, July 8, 2011 ª2011 Elsevier Inc.GADD45 proteins. In fact, various TDG-deaminase-GADD45
complexes and possibly different TET proteins may be utilized
for demethylation associated with distinct developmental pro-
cesses and reprogramming events.
Our observation of the lack of deamination-induced transition
mutations in Tdg mutant MEFs and Tdg knockdown cells at
promoters that undergo TDG-dependent protection from
hypermethylation and demethylation suggests that TDG has a
role not only in repairing deamination products, but also in
initiating the DNA demethylation process, thus controlling the
potentially mutagenic deaminase activity of AID. It is possible
that initiation is regulated by targeting of the AID-TDG-GADD45a
complex to relevant promoter/enhancers or by the optimal recip-
rocal amounts of these proteins in the complex, as TDG affects
AID levels and/or stability (Figure 6G). Given the frequent CpG
transition mutations and hypermethylation of tumor suppressor
gene promoters in human cancer, inactivation of TDG and its
demethylating complex or altered relative amounts of TDG,
AID, and GADD45a may play a role in tumor formation.EXPERIMENTAL PROCEDURES
Derivation of Tdg Null and Tdg Knockin Mice
Tdg null and Tdg knockin mice were generated by homologous recombination
of positive-negative selection targeting constructs in R1 ES cells. ES clones
carrying the targeted Tdg locus were injected into C57/BL6 blastocysts to
generate chimeric mice. The chimeric mice were backcrossed into the C57/
BL6 line for at least eight generations.
Isolation of MEFs
Mouse embryo fibroblasts (MEFs) were prepared as previously described
(Cortellino et al., 2003) from embryos harvested at E10.5 and were grown in
DMEM supplemented with 15% fetal bovine serum.
Isolation of Primordial Germ Cells
PGCs were isolated from E11 germinal ridges dissected by pipetting up-down
and trypsin digestion. PGCs stained with anti-SSEA1 antibody were sorted by
FACS. The morphology of the collected PGCs was evaluated after phospha-
tase alkaline staining to confirm cellular specificity.
Analysis of DNA Methylation by Bisulfite Modification Sequencing
Genomic DNA was subjected to the sodium bisulfite modification reaction, as
previously described (Howard et al., 2009). Products from the bisulfite reac-
tions were amplified by PCR using primers designed with the MethPrimer
software at http://www.urogene.org/methprimer/. Purified PCR products
were subcloned into pGEM T-Easy vector (Invitrogen), and individual inserts
from 10–15 clones were sequenced. Comparisons of methylation levels
weremade using the two-sided Fisher’s exact test at the 5%significance level.
Analysis of Active DNA Demethylation
P19, P19 C8, P19 C7, and P19 scrambled shRNA cells were transfected with
unmethylated or SssI in vitro-methylated Oct4::EGFP reporter plasmid. Cells
were visualized for GFP expression 12 hr after transfection. Transfected
plasmid was recovered with QIAGEN Midikit and then processed for bisulfite
treatment.
ACCESSION NUMBERS
Microarray data were submitted to ArrayExpress with accession number
E-MEXP-2610.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures,
seven figures, and two tables and can be found with this article online at
doi:10.1016/j.cell.2011.06.020.
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